Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.19.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2019
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of March 31, 2019 and December 31, 2018 (in thousands):

 

 

 

March 31, 2019

 

 

December 31, 2018

 

External research and preclinical development

 

$

6,782

 

 

$

10,119

 

Employee compensation and benefits

 

 

1,331

 

 

 

2,985

 

Professional fees

 

 

787

 

 

 

618

 

Facilities and other

 

 

186

 

 

 

171

 

 

 

$

9,086

 

 

$

13,893